Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
Clinical trial NCT05767034 · COMPLETED
Trial details
- NCT number
- NCT05767034
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2025-09-10
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.